• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2020-2022 年期间,日本某医疗中心内医护人员 SARS-CoV-2 血清阳性率上升且感染传播悄无声息。

Increased SARS-CoV-2 seroprevalence and spread of infection without awareness among healthcare workers through 2020-2022 in a Japanese medical center.

机构信息

Department of General Medicine, Juntendo University Faculty of Medicine, Hongo 2-1-2, Bunkyo-Ku, Tokyo, 113-8421, Japan.

Department of Safety and Health Promotion, Juntendo University, Tokyo, Japan.

出版信息

Sci Rep. 2023 Mar 27;13(1):4941. doi: 10.1038/s41598-023-32193-4.

DOI:10.1038/s41598-023-32193-4
PMID:36973531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10040914/
Abstract

Despite Japan's high vaccination coverage, daily numbers of new COVID-19 cases have been high. However, studies on the seroprevalence among Japanese people and the causative factors for rapid spread have remained limited. In this study, we aimed to examine the seroprevalence and associated factors in healthcare workers (HCWs) of a medical center in Tokyo using blood samples drawn at annual check-ups from 2020 to 2022. We found that of the 3,788 HCWs in 2022 (by mid-June), 669 were seropositive for N-specific antibodies (tested by Roche Elecsys Anti-SARS-CoV-2 assay); the seroprevalence surged from 0.3% in 2020 and 1.6% in 2021 to 17.7% in 2022. Notably, our study found 325 (48.6%; 325/669) cases were infected without awareness. Among those with a previously PCR-confirmed SARS-CoV-2 infection during the past three years, 79.0% (282/357) were found after January 2022, after the Omicron variant was first detected in Tokyo at the end of 2021. This study indicates the fast spread of the SARS-CoV-2 among HCWs during the Omicron surge in Japan. The high percentage of infection without awareness may be a key driving factor causing rapid person-to-person transmission, as shown in this medical center with high vaccination coverage and strict infection control measures.

摘要

尽管日本的疫苗接种率很高,但每日新增 COVID-19 病例数量仍然很高。然而,关于日本人中的血清流行率以及导致快速传播的因素的研究仍然有限。在这项研究中,我们旨在使用 2020 年至 2022 年期间在年度体检中抽取的血液样本,检查东京一家医疗中心的医护人员(HCWs)中的血清流行率和相关因素。我们发现,在 2022 年(截至 6 月中旬)的 3788 名 HCWs 中,有 669 人对 N 特异性抗体呈血清阳性(通过罗氏 Elecsys Anti-SARS-CoV-2 检测);血清流行率从 2020 年的 0.3%和 2021 年的 1.6%飙升至 2022 年的 17.7%。值得注意的是,我们的研究发现 325 例(48.6%;325/669)是在没有意识的情况下感染的。在过去三年中经 PCR 确诊的 SARS-CoV-2 感染患者中,有 79.0%(282/357)是在 2022 年 1 月之后发现的,此前 2021 年底东京首次发现了奥密克戎变异株。这项研究表明,在日本奥密克戎激增期间,SARS-CoV-2 在 HCWs 中迅速传播。高比例的无症状感染可能是导致人际快速传播的关键驱动因素,这在接种率高且感染控制措施严格的这家医疗中心中得到了体现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38c/10042837/03d7c76c41a0/41598_2023_32193_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38c/10042837/03d7c76c41a0/41598_2023_32193_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38c/10042837/03d7c76c41a0/41598_2023_32193_Fig1_HTML.jpg

相似文献

1
Increased SARS-CoV-2 seroprevalence and spread of infection without awareness among healthcare workers through 2020-2022 in a Japanese medical center.2020-2022 年期间,日本某医疗中心内医护人员 SARS-CoV-2 血清阳性率上升且感染传播悄无声息。
Sci Rep. 2023 Mar 27;13(1):4941. doi: 10.1038/s41598-023-32193-4.
2
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.在 COVID-19 大流行的第一波和第二波期间,一家三级癌症中心的癌症患者和医护人员中 SARS-CoV-2 抗体的血清阳性率的平行进化和差异:canSEROcov-II 横断面研究。
Eur J Cancer. 2022 Apr;165:13-24. doi: 10.1016/j.ejca.2022.01.005. Epub 2022 Feb 1.
3
SARS-CoV-2 seroprevalence among healthcare workers in a highly vaccinated Japanese medical center from 2020-2023.2020-2023 年日本一家高度接种疫苗的医疗中心医护人员中 SARS-CoV-2 的血清流行率。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2337984. doi: 10.1080/21645515.2024.2337984. Epub 2024 Apr 15.
4
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.印度医护人员中 SARS-CoV-2 抗体的血清阳性率及其对感染控制实践的影响。
Indian J Med Res. 2021;153(1 & 2):207-213. doi: 10.4103/ijmr.IJMR_3911_20.
5
Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.MERS-CoV 流行地区高风险医护人员中 SARS-CoV-2 的血清流行率。
J Infect Public Health. 2021 Sep;14(9):1268-1273. doi: 10.1016/j.jiph.2021.08.029. Epub 2021 Aug 25.
6
Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers.SARS-CoV-2 抗体的血清阳性率以及 6 个月内降低再感染风险:一项针对 44000 名医护人员的丹麦观察性队列研究。
Clin Microbiol Infect. 2022 May;28(5):710-717. doi: 10.1016/j.cmi.2021.09.005. Epub 2021 Sep 17.
7
Pre-Vaccination Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Workers at Three Japanese Hospitals.日本三家医院工作人员接种疫苗前抗严重急性呼吸综合征冠状病毒2抗体血清流行率
J Nippon Med Sch. 2022 Nov 9;89(5):513-519. doi: 10.1272/jnms.JNMS.2022_89-511. Epub 2022 May 30.
8
Seroprevalence of SARS-CoV-2 antibodies among Japanese healthcare workers from 2020 to 2022 as assayed by two commercial kits.2020 年至 2022 年日本医护人员中两种商业试剂盒检测到的 SARS-CoV-2 抗体血清阳性率。
Sci Rep. 2024 Feb 7;14(1):3102. doi: 10.1038/s41598-024-53656-2.
9
COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.COVID-19 在第一波和第二波疫情(2020 年)期间综合癌症中心工作人员中的流行情况:西班牙加泰罗尼亚的一项血清流行率研究。
BMJ Open. 2022 Apr 21;12(4):e056637. doi: 10.1136/bmjopen-2021-056637.
10
Two-Year Seroprevalence Surveys of SARS-CoV-2 Antibodies among Outpatients and Healthcare Workers in Ehime, Japan.日本爱媛县门诊患者和医护人员中SARS-CoV-2抗体的两年血清流行率调查
Jpn J Infect Dis. 2022 Sep 22;75(5):523-526. doi: 10.7883/yoken.JJID.2022.155. Epub 2022 May 31.

引用本文的文献

1
Risk of COVID-19 infection among frontline healthcare workers during the COVID-19 pandemic.新型冠状病毒肺炎大流行期间一线医护人员感染新型冠状病毒肺炎的风险
World J Virol. 2025 Jun 25;14(2):99663. doi: 10.5501/wjv.v14.i2.99663.
2
SARS-CoV-2 infection rates and associated risk factors in healthcare workers: systematic review and meta-analysis.医护人员中新型冠状病毒2型感染率及相关危险因素:系统评价与荟萃分析
Sci Rep. 2025 Feb 8;15(1):4705. doi: 10.1038/s41598-025-89472-5.
3
Characteristics of Lung Cancer Patients With Asymptomatic or Undiagnosed SARS-CoV-2 Infections.

本文引用的文献

1
Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan.日本无症状 SARS-CoV-2 感染的流行率。
JAMA Netw Open. 2022 Dec 1;5(12):e2247704. doi: 10.1001/jamanetworkopen.2022.47704.
2
Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.mRNA 疫苗接种与美国基本和前线工作人员中 COVID-19 的临床和病毒学特征的关联。
JAMA. 2022 Oct 18;328(15):1523-1533. doi: 10.1001/jama.2022.18550.
3
Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection.
无症状或未确诊 SARS-CoV-2 感染的肺癌患者特征。
Clin Lung Cancer. 2024 Nov;25(7):612-618. doi: 10.1016/j.cllc.2024.07.007. Epub 2024 Jul 20.
4
SARS-CoV-2 seroprevalence among healthcare workers in a highly vaccinated Japanese medical center from 2020-2023.2020-2023 年日本一家高度接种疫苗的医疗中心医护人员中 SARS-CoV-2 的血清流行率。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2337984. doi: 10.1080/21645515.2024.2337984. Epub 2024 Apr 15.
5
Seroprevalence of SARS-CoV-2 antibodies among Japanese healthcare workers from 2020 to 2022 as assayed by two commercial kits.2020 年至 2022 年日本医护人员中两种商业试剂盒检测到的 SARS-CoV-2 抗体血清阳性率。
Sci Rep. 2024 Feb 7;14(1):3102. doi: 10.1038/s41598-024-53656-2.
COVID-19 加强针接种后免疫反应的持久性及其与 COVID-19 奥密克戎感染的关联。
JAMA Netw Open. 2022 Sep 1;5(9):e2231778. doi: 10.1001/jamanetworkopen.2022.31778.
4
SARS-CoV-2 Infection in Health Care Workers of Trieste (North-Eastern Italy), 1 October 2020-7 February 2022: Occupational Risk and the Impact of the Omicron Variant.2020 年 10 月 1 日至 2022 年 2 月 7 日意大利东北部的的里雅斯特卫生保健工作者中的 SARS-CoV-2 感染:职业风险和奥密克戎变异株的影响。
Viruses. 2022 Jul 28;14(8):1663. doi: 10.3390/v14081663.
5
Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity.奥密克戎变异株感染的知晓情况在近期新冠血清阳性的成年人中。
JAMA Netw Open. 2022 Aug 1;5(8):e2227241. doi: 10.1001/jamanetworkopen.2022.27241.
6
Clinical Characteristics of Patients Who Contracted the SARS-CoV-2 Omicron Variant from an Outbreak in a Single Hospital.单一医院爆发的 SARS-CoV-2 奥密克戎变异株感染患者的临床特征。
Yonsei Med J. 2022 Aug;63(8):790-793. doi: 10.3349/ymj.2022.63.8.790.
7
Percentage of Asymptomatic Infections among SARS-CoV-2 Omicron Variant-Positive Individuals: A Systematic Review and Meta-Analysis.严重急性呼吸综合征冠状病毒2型奥密克戎变异株阳性个体中无症状感染的百分比:一项系统评价和荟萃分析
Vaccines (Basel). 2022 Jun 30;10(7):1049. doi: 10.3390/vaccines10071049.
8
Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection.有或无前感染史的三剂疫苗接种医护人员感染奥密克戎后的免疫反应
Lancet Infect Dis. 2022 Jul;22(7):943-945. doi: 10.1016/S1473-3099(22)00362-0. Epub 2022 Jun 9.
9
Infection Prevention and Control of Severe Acute Respiratory Syndrome Coronavirus 2 in Health Care Settings.医疗机构严重急性呼吸综合征冠状病毒 2 感染预防与控制。
Infect Dis Clin North Am. 2022 Jun;36(2):309-326. doi: 10.1016/j.idc.2022.01.001. Epub 2022 Feb 1.
10
Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2.感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变异株的2019冠状病毒病(COVID-19)患者的临床特征
Front Med (Lausanne). 2022 May 9;9:912367. doi: 10.3389/fmed.2022.912367. eCollection 2022.